A JP Morgan note lowers STZ's 12-month target from $165 to $133 and keeps a Neutral rating, citing softer consumer discretionary spending and tighter household budgets. The revised target implies subdued margin expansion and a rangebound stock path until demand re-accelerates. STZ’s Modelo and Corona portfolio provides structural support, helping it weather industry headwinds better than peers.
U.S. alcohol makers, including Constellation Brands, face renewed pressure as tariffs re-ignite a dispute with Canada, a key export market. If access remains restricted, STZ could see weaker Canadian sales, potentially harming volumes and margins in North America. Investors should monitor tariff developments and Canada’s responses for near-term impact on STZ.
Constellation Brands faces renewed pressure after a Death Cross, with the 50-day SMA below the 200-day SMA. Berkshire Hathaway reduced its Constellation stake by about 95%, signaling a capital reallocation that could weigh sentiment. Despite a Q1 beat, cautious consumer spending and a flat organic sales outlook keep STZ exposed to further weakness.
Constellation Brands topped expectations with a $3.43 per share earnings beat and $2.43 billion in revenue, underscoring strength in Modelo Especial and Corona Extra. Management kept the fiscal-year adjusted EPS guidance at $11.20-$11.90, highlighting continued brand momentum and distribution expansion. The results suggest a near-term stock move and potential multiple expansion if consumer demand for core brands remains resilient.
Constellation Brands (STZ) is set to release its Q1 results after the June 30 close. Analysts expect EPS of $3.25 on about $2.4 billion in revenue, compared with $3.22 and $2.52B a year ago. The May 21 election of Morgan Flatley to the independent board may bolster governance perception and support a constructive near-term outlook around the print.
Constellation Brands has withdrawn its fiscal 2028 outlook, citing weaker demand and ongoing macroeconomic uncertainty. Despite exceeding fourth-quarter expectations with strong beer and wine sales, the company's net sales for fiscal 2026 declined by 3%, indicating potential challenges ahead for STZ’s growth trajectory.